CONTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 6.783
EU - Europa 3.189
AS - Asia 1.256
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 4
OC - Oceania 4
Totale 11.277
Nazione #
US - Stati Uniti d'America 6.655
IT - Italia 678
DE - Germania 677
CN - Cina 462
SG - Singapore 427
SE - Svezia 365
IE - Irlanda 359
RU - Federazione Russa 282
UA - Ucraina 207
GB - Regno Unito 206
AT - Austria 125
CA - Canada 125
HK - Hong Kong 116
FI - Finlandia 102
IN - India 70
DK - Danimarca 62
TR - Turchia 54
ID - Indonesia 46
FR - Francia 39
VN - Vietnam 38
BE - Belgio 37
KR - Corea 17
BR - Brasile 16
CZ - Repubblica Ceca 13
EU - Europa 13
NL - Olanda 13
IR - Iran 10
JP - Giappone 8
CH - Svizzera 6
AU - Australia 4
PE - Perù 4
RO - Romania 4
CL - Cile 3
ES - Italia 3
AR - Argentina 2
EG - Egitto 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 11.277
Città #
Ann Arbor 2.175
Chandler 534
Woodbridge 522
Frankfurt am Main 425
Wilmington 375
Singapore 349
Dublin 348
Houston 328
Fairfield 298
Jacksonville 265
Ashburn 257
Dearborn 250
Milan 223
New York 153
Santa Clara 151
Seattle 138
Princeton 130
Vienna 122
Hong Kong 115
Cambridge 106
Nanjing 95
Shanghai 75
Boardman 54
Lachine 51
Jakarta 46
Helsinki 40
Brussels 36
Lawrence 36
Beijing 33
Nanchang 33
Dong Ket 30
Ottawa 30
Guangzhou 27
Pune 24
Rome 24
Shenyang 23
Fremont 22
Altamura 21
San Diego 20
Tianjin 19
Andover 18
Falls Church 18
Toronto 18
Carate Brianza 17
Munich 16
Norwalk 16
Jiaxing 15
Dallas 14
Edmonton 14
Hebei 14
London 14
Changsha 13
Jinan 13
Monza 13
Brno 12
Como 12
Ningbo 12
Kunming 11
Los Angeles 11
Mountain View 11
Zhengzhou 11
Leawood 10
Lissone 10
Detroit 9
Monmouth Junction 9
Chicago 8
Lappeenranta 8
Taizhou 8
São Paulo 7
Bologna 6
Gaziantep 6
Hangzhou 6
Hefei 6
Lecco 6
Pisa 6
Rozzano 6
Vadodara 6
Bergamo 5
Bielefeld 5
Bonn 5
Busto Arsizio 5
Daejeon 5
Grafing 5
Nürnberg 5
Redmond 5
Rho 5
Ripalta Cremasca 5
Verona 5
Desio 4
Fuzhou 4
Haikou 4
Huizen 4
Lima 4
Melegnano 4
Misinto 4
Napoli 4
San Mateo 4
Verdellino 4
Washington 4
Auburn Hills 3
Totale 8.515
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 399
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 352
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 348
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 295
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 289
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 285
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 283
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 264
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 264
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 255
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 247
Anorexia nervosa in adolescent girls and celiac disease serology 246
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 246
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 246
The one-carbon metabolism in anorexia nervosa of the restrictive type 237
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 233
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 224
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 212
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 202
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 201
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 198
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 191
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 181
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 178
Behavioural anomalies in neurodegenerative diseases: role of the immune response 178
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 170
Anorexia nervosa of the restrictive type and celiac disease in adolescence 168
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 167
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 166
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 164
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 161
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 161
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 161
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 157
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 157
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 153
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 151
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 150
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 150
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 149
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 147
Affective states and pathology in adolescents with borderline personality 136
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 135
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 135
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 134
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 134
the MonzALS collaborative network 130
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 130
New insights into the genetic etiology of Alzheimer's disease and related dementias 127
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 124
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 123
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 121
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 118
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 115
Whole-blood global DNA methylation and phenotypic variability in ALS 114
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 107
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 106
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 104
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 102
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 102
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 101
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 100
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 100
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 99
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 93
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 91
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 78
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 74
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 50
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 40
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 38
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 34
Totale 11.981
Categoria #
all - tutte 37.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020870 0 0 0 0 0 0 298 113 144 140 152 23
2020/20211.970 127 82 204 248 186 162 201 148 166 178 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20251.178 171 277 212 113 238 166 1 0 0 0 0 0
Totale 11.981